Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection
Zamora FJ, Dowers E, Yasin F, Ogbuagu O. Dolutegravir And Lamivudine Combination For The Treatment Of HIV-1 Infection. HIV/AIDS - Research And Palliative Care 2019, 11: 255-263. PMID: 31749636, PMCID: PMC6817767, DOI: 10.2147/hiv.s216067.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsHIV-1 infectionCombination antiretroviral therapyReverse transcriptase inhibitor lamivudineNucleoside reverse transcriptase inhibitor lamivudineSingle-tablet regimensTreatment-naive peopleTreatment of HIVClinical trial dataIntegrase inhibitor dolutegravirLong-term toxicityUnfavorable toxicity profileARV optionsEffective ARVAntiretroviral therapyLamivudine combinationInhibitor lamivudineToxicity profileRobust efficacyTrial dataDolutegravirInfectionDTG/3TCHIVTreatmentDrug development